Parkinson's disease (PD) is a neurodegenerative disorder that affects millions of people worldwide. Early diagnosis and treatment are essential for improving quality of life and slowing the progression of the disease.
Recent research has shown that changes in the levels and ratios of certain lipids can be used to identify people who are at risk for developing PD. Blaine Roberts, Ph.D., will discuss his work using ion mobility mass spectrometry (TIMS) to identify disease-specific lipid isomers that could be used for the early detection of PD.
Join Blaine Roberts, Ph.D., department of Biochemistry at Emory University, as he discusses his research into how lipids can be used as biomarkers for Parkinson's disease.
In this webinar, you will learn:
This webinar would be of interest to:
Blaine Roberts, Ph.D., Associate Professor, Department of Biochemistry, Emory University, Atlanta, GA, USA
Blaine Roberts is an Associate Professor of Biochemistry at Emory University. His research focuses on the use of mass spectrometry to study lipid metabolism in neurodegenerative diseases. He is particularly interested in using lipid biomarkers to identify people who are at risk for developing PD and to track the progression of the disease. His lab received a Michael J. Fox Foundation for Parkinson's Research award called "Validation of blood biomarkers for the detection of Parkinson’s Disease."
For Research Use Only. Not for use in clinical diagnostic procedures.